Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dexmedetomidine Improves Anxiety-like Behaviors in Sleep-Deprived Mice by Inhibiting the p38/MSK1/NFκB Pathway and Reducing Inflammation and Oxidative Stress.

Brain sciences·2023
Same author

Erratum: Complete head cerebral sensitivity mapping for diffuse correlation spectroscopy using subject-specific magnetic resonance imaging models: errata.

Biomedical optics express·2023
Same author

Efficacy analysis of empirical bismuth quadruple therapy, high-dose dual therapy, and resistance gene-based triple therapy as a first-line <i>Helicobacter pylori</i> eradication regimen - An open-label, randomized trial.

Open medicine (Warsaw, Poland)·2023
Same author

Pulmonary interleukin 1 beta/serum amyloid A3 axis promotes lung metastasis of hepatocellular carcinoma by facilitating the pre-metastatic niche formation.

Journal of experimental & clinical cancer research : CR·2023
Same author

Legionella pneumonia complicated with rhabdomyolysis and acute kidney injury diagnosed by metagenomic next-generation sequencing: a case report.

World journal of emergency medicine·2023
Same author

Spike-frequency adaptation inhibits the pairwise spike correlation.

Frontiers in neuroscience·2023

Related Experiment Video

Updated: May 7, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.6K

Targeting AURKA with multifunctional nanoparticles in CRPC therapy.

Bin Deng1,2, Binghu Ke1, Qixing Tian1

  • 1Department of Urology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, China.

Journal of Nanobiotechnology
|December 29, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces novel nanoparticles combining photothermal therapy, chemotherapy, and immunotherapy to treat castration-resistant prostate cancer (CRPC). The treatment effectively inhibits tumor growth and enhances the anti-tumor immune response in preclinical models.

Keywords:
Aurora-A kinase (AURKA)Castration-resistant prostate cancer (CRPC)ChemotherapyImmunotherapyNanoparticlesPhotothermal therapy

More Related Videos

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
14:10

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

15.9K
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

5.9K

Related Experiment Videos

Last Updated: May 7, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.6K
Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
14:10

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

15.9K
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

5.9K

Area of Science:

  • Oncology
  • Nanotechnology
  • Immunotherapy

Background:

  • Castration-resistant prostate cancer (CRPC) is a challenging malignancy with limited treatment options.
  • Aurora-A kinase (AURKA) is overexpressed in prostate cancer (PCa) and linked to poor outcomes.
  • CRPC is often associated with a suppressed immune microenvironment.

Purpose of the Study:

  • To investigate the efficacy of T cell membrane-encapsulated nanoparticles (CM-AMS@AD) as a triple-combination therapy (photothermal, chemotherapy, immunotherapy) for CRPC.
  • To evaluate the anti-tumor effects and immune modulation of CM-AMS@AD NPs in vitro and in vivo.

Main Methods:

  • Bioinformatics analysis of TCGA-PRAD and GEO datasets to identify AURKA overexpression and immune cell reduction in CRPC.
  • Synthesis and characterization of T cell membrane-biomimetic nanoparticles loaded with Alisertib (AURKA inhibitor) and DTX (chemotherapy drug).
  • In vitro assays assessing cell proliferation, cell cycle, and apoptosis; in vivo studies evaluating tumor growth, apoptosis, and immune cell profiles.

Main Results:

  • CM-AMS@AD NPs demonstrated good stability and uniformity (158 nm average diameter).
  • In vitro, NPs inhibited CRPC cell proliferation, arrested cells in G2/M phase, and induced apoptosis.
  • In vivo, NPs accumulated in tumors, significantly suppressed tumor growth, promoted apoptosis, enhanced dendritic cell maturation, and improved CD8+/CD4+ T cell ratios.

Conclusions:

  • CM-AMS@AD NPs represent a promising strategy for CRPC treatment by integrating photothermal, chemotherapy, and immunotherapy.
  • This novel nanoparticle formulation shows significant potential for clinical translation in managing advanced prostate cancer.